cirsilineol has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, JS; Kim, GO; Park, DH | 1 |
| Ai, M; Li, L; Li, Y; Lin, S; Wu, T; Yang, N; Zhang, M | 1 |
2 other study(ies) available for cirsilineol and Innate Inflammatory Response
| Article | Year |
|---|---|
Protective Effects of Cirsilineol against Lipopolysaccharide-Induced Inflammation; Insights into HO-1, COX-2, and iNOS Modulation.
Topics: Animals; Cyclooxygenase 2; Endothelial Cells; Flavones; Heme Oxygenase-1; Humans; Inflammation; Lipopolysaccharides; Mice; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II | 2023 |
Cirsilineol attenuates LPS-induced inflammation in both in vivo and in vitro models via inhibiting TLR-4/NFkB/IKK signaling pathway.
Topics: Acute Lung Injury; Animals; Disease Models, Animal; Flavones; I-kappa B Kinase; Inflammation; Lipopolysaccharides; Male; Mice; NF-kappa B; RAW 264.7 Cells; Signal Transduction; Toll-Like Receptor 4 | 2021 |